Medical Devices India

India Sepsis Diagnostics Market Analysis, 2024–2034

India Sepsis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Biomarker, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $18.8 Mn Estimated value
Estimate 2025 $21.0 Mn 2% of the global market
Projected 2034 $57.9 Mn 175.1% Adds $36.8 Mn over 9 forecast years
CAGR 2025–2034 11.9% Faster than 50% of 173 Medical Devices markets here
Key players 5
  • India is 1.97% of the global market.
  • In APAC, the largest is China at $82.4 Mn.
  • Fastest growing: India (this report) at 11.9% a year.
  • India ranks 3rd of 10 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$36.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Sepsis Diagnostics Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $18.8 Mn — —
2025 (base) $21.0 Mn +$2.2 Mn —
2026 (forecast) $23.5 Mn +$2.5 Mn +11.9%
2027 (forecast) $26.3 Mn +$2.8 Mn +25.2%
2028 (forecast) $29.5 Mn +$3.1 Mn +40.1%
2029 (forecast) $33.0 Mn +$3.5 Mn +56.8%
2030 (forecast) $36.9 Mn +$3.9 Mn +75.4%
2031 (forecast) $41.3 Mn +$4.4 Mn +96.3%
2032 (forecast) $46.2 Mn +$4.9 Mn +119.7%
2033 (forecast) $51.7 Mn +$5.5 Mn +145.8%
2034 (forecast) $57.9 Mn +$6.2 Mn +175.1%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.07 Bn
  2. North America $451.7 Mn
  3. US $441.9 Mn
  4. APAC $227.3 Mn
  5. Europe $206.3 Mn
  6. Canada $92.4 Mn
  7. China $82.4 Mn
  8. Japan $61.1 Mn
  9. Latin America $55.8 Mn
  10. Middle East $49.3 Mn
  11. Germany $38.0 Mn
  12. France $32.1 Mn
  13. UK $26.1 Mn
  14. Italy $25.3 Mn
  15. Brazil $23.5 Mn
  16. Ecuador $21.2 Mn
  17. Spain $20.1 Mn
  18. India (this report) $21.0 Mn
  19. Saudi Arabia $19.8 Mn
  20. Africa $17.2 Mn
  21. Mexico $16.7 Mn
  22. Australia $12.9 Mn
  23. Russia $9.9 Mn
  24. New Zealand $9.4 Mn
  25. South Africa $7.7 Mn
  26. UAE $4.9 Mn
  27. Egypt $2.9 Mn
  28. Philippines $2.1 Mn
  29. Hong Kong $1.9 Mn
  30. Malaysia $1.4 Mn
  31. Singapore $1.4 Mn
  32. Thailand $1.3 Mn
  33. Kenya $0.9 Mn

The India Sepsis Diagnostics Market Analysis Executive Summary

Sepsis diagnostics help doctors spot life-threatening sepsis early and find the germ causing it, using blood tests and biomarkers.

Key segments of the sepsis Diagnostics market include technology (Blood Culture, Molecular Diagnostics and Biomarker Assays) and biomarker (Procalcitonin, Lactate and Monocyte Width).

India Sepsis Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the sepsis Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the sepsis Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the sepsis Diagnostics market.

Competitive Landscape for Sepsis Diagnostics Market in India

The sepsis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Sepsis Diagnostics Market in India

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how sepsis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in India.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Sepsis Diagnostics right now, from free public sources.

Clinical trials

6 active trials in India

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. AstraZeneca 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Artcline GmbH 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. ImmunityBio, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Bayer AG 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. CorMedix Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 61 papers since 2021 (worldwide)

  1. Liquid contactable colorimetric sensor array for bacteria discrimination. Talanta, 2026
  2. From sepsis biomarker discovery to regulated in vitro diagnostics: evidence, certification status and implementation gaps. Frontiers in medical technology, 2026
  3. Isolating viable bacteria from positive blood cultures: impedance cytometry analysis. Biomedical microdevices, 2026
  4. Analytical and Clinical Evaluation of a Fully Automated Direct-from-Whole-Blood Multiplex PCR Assay Using Large-Volume Reverse Elution for Rapid Bloodstream Infection Diagnosis. Antibiotics (Basel, Switzerland), 2026
  5. Evaluation of blood culture bottles and instruments for cost, affordability, and supply chain to meet global equity in sepsis diagnostics. The Lancet. Microbe, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Sepsis Diagnostics in context

India compared

  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 10th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 11th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 7.4% of people (2025). World: 10.4% of people (2025). 11th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How many clinical trials on Sepsis Diagnostics are running in India?
6 studies are recruiting, active or about to start in India.[4]
How much research is published on Sepsis Diagnostics?
PubMed lists 61 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Sepsis Diagnostics in India? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Ambulance Services: The First Link in Emergency CareMore than half of deaths in low- and middle-income countries come from conditions emergency care could treat… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Back to Catalogue
Keep exploring

Related Medical Devices reports in India

See all
Same topic, other categories

Related on diagnostics and lab testing and infectious diseases

See the topic